AURX
Price
$1.32
Change
-$0.18 (-12.00%)
Updated
Jun 25 closing price
Capitalization
61.81M
BETRF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Jun 26 closing price
Capitalization
11.14M
Interact to see
Advertisement

AURX vs BETRF

Header iconAURX vs BETRF Comparison
Open Charts AURX vs BETRFBanner chart's image
Nuo Therapeutics
Price$1.32
Change-$0.18 (-12.00%)
Volume$51.84K
Capitalization61.81M
BETTERLIFE PHARMA
Price$0.06
Change-$0.00 (-0.00%)
Volume$1K
Capitalization11.14M
AURX vs BETRF Comparison Chart in %
Loading...
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURX vs. BETRF commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURX is a Hold and BETRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (AURX: $1.32 vs. BETRF: $0.06)
Brand notoriety: AURX and BETRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURX: 617% vs. BETRF: 3%
Market capitalization -- AURX: $61.81M vs. BETRF: $11.14M
AURX [@Biotechnology] is valued at $61.81M. BETRF’s [@Biotechnology] market capitalization is $11.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURX’s FA Score shows that 0 FA rating(s) are green whileBETRF’s FA Score has 0 green FA rating(s).

  • AURX’s FA Score: 0 green, 5 red.
  • BETRF’s FA Score: 0 green, 5 red.
According to our system of comparison, BETRF is a better buy in the long-term than AURX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURX’s TA Score shows that 3 TA indicator(s) are bullish while BETRF’s TA Score has 2 bullish TA indicator(s).

  • AURX’s TA Score: 3 bullish, 4 bearish.
  • BETRF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AURX is a better buy in the short-term than BETRF.

Price Growth

AURX (@Biotechnology) experienced а -12.00% price change this week, while BETRF (@Biotechnology) price change was -18.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURX($61.8M) has a higher market cap than BETRF($11.1M). AURX YTD gains are higher at: -5.714 vs. BETRF (-15.724). AURX has higher annual earnings (EBITDA): -2.39M vs. BETRF (-3.14M). AURX has more cash in the bank: 55.7K vs. BETRF (18.7K). AURX has less debt than BETRF: AURX (148K) vs BETRF (1.24M). AURX has higher revenues than BETRF: AURX (1.62M) vs BETRF (0).
AURXBETRFAURX / BETRF
Capitalization61.8M11.1M557%
EBITDA-2.39M-3.14M76%
Gain YTD-5.714-15.72436%
P/E RatioN/AN/A-
Revenue1.62M0-
Total Cash55.7K18.7K298%
Total Debt148K1.24M12%
FUNDAMENTALS RATINGS
AURX vs BETRF: Fundamental Ratings
AURX
BETRF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4065
P/E GROWTH RATING
1..100
10044
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AURX's Valuation (95) in the null industry is in the same range as BETRF (100). This means that AURX’s stock grew similarly to BETRF’s over the last 12 months.

AURX's Profit vs Risk Rating (74) in the null industry is in the same range as BETRF (100). This means that AURX’s stock grew similarly to BETRF’s over the last 12 months.

AURX's SMR Rating (100) in the null industry is in the same range as BETRF (100). This means that AURX’s stock grew similarly to BETRF’s over the last 12 months.

AURX's Price Growth Rating (40) in the null industry is in the same range as BETRF (65). This means that AURX’s stock grew similarly to BETRF’s over the last 12 months.

BETRF's P/E Growth Rating (44) in the null industry is somewhat better than the same rating for AURX (100). This means that BETRF’s stock grew somewhat faster than AURX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AURXBETRF
RSI
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BETRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUFAF12.20N/A
N/A
Hufvudstaden AB
OROVY84.71N/A
N/A
Orient Overseas International Ltd.
SEIGF15.96N/A
N/A
Semperit Ag Holding
FRFFF18.29N/A
N/A
Fairfax Financial Holdings Ltd.
ROOOF0.25-0.01
-4.87%
NORTHSTAR CLEAN TECHNOLOGIES INC.

AURX and

Correlation & Price change

A.I.dvisor tells us that AURX and ALZN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AURX and ALZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURX
1D Price
Change %
AURX100%
N/A
ALZN - AURX
27%
Poorly correlated
-0.68%
VRAX - AURX
27%
Poorly correlated
+1.95%
YECO - AURX
26%
Poorly correlated
N/A
QSI - AURX
23%
Poorly correlated
-3.47%
NCNA - AURX
23%
Poorly correlated
N/A
More

BETRF and

Correlation & Price change

A.I.dvisor tells us that BETRF and AVCTF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BETRF and AVCTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BETRF
1D Price
Change %
BETRF100%
N/A
AVCTF - BETRF
14%
Poorly correlated
N/A
BPMUF - BETRF
6%
Poorly correlated
N/A
BIXT - BETRF
3%
Poorly correlated
-5.70%
AURX - BETRF
-0%
Poorly correlated
N/A
AMGXF - BETRF
-2%
Poorly correlated
N/A
More